Back to Newsroom
Back to Newsroom

LAWSUITS FILED AGAINST TASK, CELH and ABBV - Jakubowitz Law Pursues Shareholders Claims

Thursday, 14 April 2022 11:00 AM

Jakubowitz Law

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / April 14, 2022 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Taskus, Inc. (NASDAQ:TASK)

CONTACT JAKUBOWITZ ABOUT TASK:
https://claimyourloss.com/securities/taskus-inc-loss-submission-form/?id=25981&from=1

Class Period : June 11, 2021 - January 19, 2022

Lead Plaintiff Deadline : April 25, 2022

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) TaskUs was experiencing severe financial strain and business challenges, particularly with its most important customer, Facebook; (2) the Content Security market was smaller than defendants represented and defendants' representations were based on outdated market data; (3) TaskUs improperly recognized revenue from certain key contracts; (4) defendants overstated the size of TaskUs' workforce as well as employee retention rates, and understated attrition rates; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

Celsius Holdings, Inc. (NASDAQ:CELH)

CONTACT JAKUBOWITZ ABOUT CELH:
https://claimyourloss.com/securities/celsius-holdings-inc-loss-submission-form/?id=25981&from=1

Class Period : August 12, 2021 - March 1, 2022

Lead Plaintiff Deadline : May 16, 2022

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had improperly recorded expenses for non-cash share-based compensation for second and third quarters of 2021; (2) as a result, the Company's financial statements for those periods would be restated, including to report a net loss for the third quarter of 2021; (3) there was a material weakness in Celsius's internal controls over financial reporting; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

AbbVie Inc. (NYSE:ABBV)

CONTACT JAKUBOWITZ ABOUT ABBV:
https://claimyourloss.com/securities/abbvie-inc-loss-submission-form/?id=25981&from=1

Class Period : April 30, 2021 - August 31, 2021

Lead Plaintiff Deadline : June 6, 2022

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) safety concerns about Pfizer Inc.'s drug Xeljanz extended to Abbvie's drug Rinvoq and to other Janus kinase enzyme inhibitor drugs; (2) as a result, it was likely that the U.S. Food and Drug Administration would require additional safety warnings for Rinvoq and would delay the approval of additional treatment indications for Rinvoq; and (3) therefore, defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.

Jakubowitz Law, Thursday, April 14, 2022, Press release picture

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE : Jakubowitz Law

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: